These tumor-derived exosomes also increased the secretion of the pro-inflammatory cytokines IL-1β, IL-6, and IL-10, and decreased the release of IFNγ, IL-2, and IL-17, both in CD4+ and CD8+T cells. The gene discussed is CD8A; the disease is neoplasm.